101 related articles for article (PubMed ID: 1297891)
1. Effect of amphotericin B alone or in combination with rifampicin on phagocytosis of Candida species by human polymorphonuclear leukocytes.
Schaumann RF; Shah PM
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):753-8. PubMed ID: 1297891
[TBL] [Abstract][Full Text] [Related]
2. Influence of free or liposomal amphotericin B on killing of Candida species by human peritoneal macrophages.
Allwinn R; Schaumann R; Shah PM
Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):163-7. PubMed ID: 8531506
[TBL] [Abstract][Full Text] [Related]
3. Effect of amphotericin B alone or in combination with rifampicin or clarithromycin against Candida species biofilms.
Del Pozo JL; Francés ML; Hernáez S; Serrera A; Alonso M; Rubio MF
Int J Artif Organs; 2011 Sep; 34(9):766-70. PubMed ID: 22094555
[TBL] [Abstract][Full Text] [Related]
4. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo.
Chalkley LJ; Trinci AP; Pope AM
Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468
[TBL] [Abstract][Full Text] [Related]
5. In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations.
Anséhn S; Granström S; Höjer H; Nilsson L; Akesson E; Lundin A; Thore A
Scand J Infect Dis Suppl; 1976; (9):62-6. PubMed ID: 795012
[TBL] [Abstract][Full Text] [Related]
6. Uptake and killing of Candida by human peritoneal macrophages and amphotericin B.
Linde HJ; Stille W; Shah PM
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):79-84. PubMed ID: 8007745
[TBL] [Abstract][Full Text] [Related]
7. Dissociated effect of amphotericin B and desoxycholate on phagocytosis of Escherichia coli by human polymorphonuclear neutrophils.
Lingaas E; Midtvedt T
Drugs Exp Clin Res; 1985; 11(11):747-54. PubMed ID: 3915464
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of amphotericin B and rifampin on Candida species.
Edwards JE; Morrison J; Henderson DK; Montgomerie JZ
Antimicrob Agents Chemother; 1980 Mar; 17(3):484-7. PubMed ID: 7425608
[TBL] [Abstract][Full Text] [Related]
9. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm.
Raad II; Hachem RY; Hanna HA; Fang X; Jiang Y; Dvorak T; Sherertz RJ; Kontoyiannis DP
Int J Antimicrob Agents; 2008 Dec; 32(6):515-8. PubMed ID: 18783924
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
11. Synergistic action of amphotericin B and rifampin against Candida species.
Beggs WH; Sarosi GA; Walker MI
J Infect Dis; 1976 Feb; 133(2):206-9. PubMed ID: 1245767
[TBL] [Abstract][Full Text] [Related]
12. [Determination of in vitro susceptibility of Candida species to amphotericin B by E-test and previously proposed MIC breakpoints on two different media].
Alp S; Sancak B; Arikan S
Mikrobiyol Bul; 2008 Apr; 42(2):293-300. PubMed ID: 18697427
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
15. Micafungin enhances neutrophil fungicidal functions against Candida pseudohyphae.
Gil-Lamaignere C; Salvenmoser S; Hess R; Müller FM
Antimicrob Agents Chemother; 2004 Jul; 48(7):2730-2. PubMed ID: 15215137
[TBL] [Abstract][Full Text] [Related]
16. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
Yang YL; Li SY; Cheng HH; Lo HJ;
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to amphotericin B in clinical isolates of Candida tropicalis.
Barchiesi F; Maracci M; Baldassarri I; Spreghini E; Giannini D; Scalise G
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):179-85. PubMed ID: 15541603
[TBL] [Abstract][Full Text] [Related]
18. The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.
Gürer US; Göçer P; Erçağ E; Erten N; Rayaman E; Gürbüz B; Uzer A; Karan A; Cevikbaş A
Int Immunopharmacol; 2006 May; 6(5):808-16. PubMed ID: 16546712
[TBL] [Abstract][Full Text] [Related]
19. Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole.
Lincopan N; Carmona-Ribeiro AM
J Antimicrob Chemother; 2006 Jul; 58(1):66-75. PubMed ID: 16636081
[TBL] [Abstract][Full Text] [Related]
20. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
Wei GX; Bobek LA
J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
